ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

BPMC Blueprint Medicines Corporation

107.19
0.19 (0.18%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Blueprint Medicines Corporation BPMC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.19 0.18% 107.19 09:00:00
始値 安値 高値 終値 前日終値
109.82 106.07 110.93 107.19 107.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
2024/4/1821:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
2024/4/1121:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
2024/4/0505:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2024/3/1207:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1207:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2024/3/0700:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0508:19EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0205:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:03EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2322:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
2024/2/2222:20EDGAR2Form 8-K - Current report
2024/2/1706:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1607:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1521:05EDGAR2Form 8-K - Current report
2024/2/1521:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
2024/2/1508:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2024/2/0122:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
2024/1/3008:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2606:13EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0822:03EDGAR2Form 8-K - Current report
2024/1/0822:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
2024/1/0606:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
2023/12/2706:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2306:09EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1822:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
2023/12/1606:23EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1405:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1222:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
2023/12/1207:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1002:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
2023/12/0808:09EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock